QuantHealth, a Tel Aviv, Israel-based AI-driven clinical trial simulation company, has secured a strategic investment, bringing its total raised to $30 million. 

Investors 

The round was led by Sanofi Ventures, the corporate venture capital arm of Sanofi, which invests globally in early-stage biotech and digital health companies aligned with Sanofi’s mission to chase the miracles of science. Areas of focus include immunology, oncology, rare diseases, vaccines, and digital innovation. 

As part of the investment, Cris De Luca, Partner at Sanofi Ventures, will join QuantHealth’s Board of Directors as an observer. 

QuantHealth Use of Funds 

The company will use the funding to scale its AI-driven platform, enhance its digital twin simulation capabilities, and expand enterprise partnerships within the pharmaceutical industry. 

About QuantHealth 

Founded in 2020, QuantHealth is a healthcare company that provides a platform to simulate clinical trials in order to accelerate and de-risk drug development. Its platform enables pharmaceutical companies to virtually simulate clinical trials using real-world data and advanced AI models. By generating millions of digital twins, QuantHealth helps predict trial outcomes, optimize protocol design, and improve trial success rates, timelines, and cost efficiency. Heaquartered in Tel Aviv, Israel, QuantHealth has access to over 350 million patient records and proprietary AI algorithms.

Funding Details 

Company: QuantHealth Ltd. 

Raised: Undisclosed

Round: Strategic Investment 

Funding Date: October 2025 

Lead Investor: Sanofi Ventures 

Additional Investors:  

Company Website: https://www.quanthealth.ai/  

Software Category: AI in Drug Development / Clinical Trial Simulation 

Source: https://www.businesswire.com/news/home/20251001876047/en/